FEATURED CONTRIBUTED CONTENT

Beyond Compliance: Regulated Content Management and the Digital Revolution


Beyond Compliance: Regulated Content Management and the Digital Revolution

Globalization of clinical trials, tightening regulatory requirements, a more competitive and collaborative commercial environment, and an increasingly mobile workforce requires life-sciences companies to standardize and improve regulated content management processes to ensure information is shared with the right people at the right time. This paper explores issues that impact the way regulated content is managed and used and what CIOs […]

August 1, 2017 More Clinical »
Expediting Drug Approval


Expediting Drug Approval

For patients with serious and rare diseases, time is of the essence, and the traditional drug development process may take far too long. To speed innovative new drugs to market, the FDA has established four expedited programs that allow the development process to be compressed and evidence of the drug’s effectiveness gathered as efficiently as […]

April 3, 2017 More Clinical »
The Future of RWE Technology – Moving Beyond Rapid Cycle Analytics


The Future of RWE Technology – Moving Beyond Rapid Cycle Analytics

In recent years, a plethora of real-world evidence (RWE) analytic platforms have emerged, giving researchers the ability to submit analysis parameters, execute analytic programs across specific data sources, and produce rapid results without custom programming. These RWE platforms facilitate shortened analysis cycle times, delivering results in minutes or hours, instead of days, weeks, or longer. […]

August 7, 2017 More Clinical »
Al Altomari: The Caring Warrior  – a 2017 PharmaVOICE 100 Honoree


Al Altomari: The Caring Warrior – a 2017 PharmaVOICE 100 Honoree

Al Altomari, Chairman and CEO of Agile Therapeutics Inc. always seeks to always do the right thing and is selfless in his contributions to both the business and on a personal level. He seeks to inspire with passion, energy, and caring. He fosters innovation by letting people make mistakes and by laughing at his own […]

August 11, 2017 More Clinical »
Keeping Up with Innovation: Institutional Review Boards and Therapeutic Specialization


Keeping Up with Innovation: Institutional Review Boards and Therapeutic Specialization

The therapeutic landscape is shifting rapidly, and it’s becoming more and more important for those involved in overseeing clinical research to be familiar with the latest breakthroughs and treatments. Increasing sophistication in the design, conduct, and analysis of clinical research complicates the review process, as IRBs must possess the expertise to understand the underlying science […]

July 14, 2017 More Clinical »
Improved Patient Outcomes and Financial Performance


Improved Patient Outcomes and Financial Performance

Neither orphan drug manufacturers nor their patients with rare diseases are served well by the traditional multi-channel model of drug delivery and patient service. A new integrated model increases adherence and improves patient outcomes, which in turn leads to better financial performance for manufacturers.

May 18, 2017 More Clinical »
Evidence Wisely: Advanced Learnings from the Field


Evidence Wisely: Advanced Learnings from the Field

In the ever-evolving healthcare landscape, stakeholders are demanding more Real-World Evidence (RWE), and more RWE is becoming available. That should mean that demand should be easy to satisfy, right? Explore this informative ebook to learn about the latest in RWE, using the ebook link below. There is also a related podcast, entitled, “The Real Value […]

May 31, 2017 More Clinical »
Bhaskar Sambasivan: A Pioneer in the Shift to Digital  – a 2017 PharmaVOICE 100 Honoree


Bhaskar Sambasivan: A Pioneer in the Shift to Digital – a 2017 PharmaVOICE 100 Honoree

Bhaskar Sambasivan, Senior VP and Global Head, Life Sciences at Cognizant, believes the factors that foster innovation are empowerment and the freedom to experiment and take risks. He challenges the status quo, bringing people and partners together, to maintain growth year over year. Mr. Sambasivan makes bold bets and encourages transformational ideas among his life […]

August 14, 2017 More Clinical »
FEEDBACK